and on our Anna and then through our updates everyone. turn you, full Elliot Thank call to start providing Kate, financial XXXX over good by quarter business results will and year morning, walk the to I you third outlook.
smaller that orally BMI approved result, foods treatment up the a a we the people weight any Plenity market administered, As a as to helps novel, prescription of while weight XX weight therapy people feel the believe management and all to is eat love. low XX. they management FDA-cleared and for satisfied as the approach way they have Plenity market we today. And is can enjoying on a reminder, weight the still as with BMI of a less with addressable portions management largest lose only so
significant clearly BMI the launch that prescribed Plenity of in capital so over served the was currently the with broad than to twice not our with quarter consumer strong that were are conditions, spectrum successful with to as We are more over We members launching other marketing as Plenity XXX% reduction for first of BMI are doing demand, units and successful XX XX,XXX as to Since is prior third to XX,XXX XX% reached quarter consumers investment with new sold this was year demonstrating challenging the new reaching gross additional across of in sold well to as compared quarter. February, in level a third product top many wave the has acquired initial seeing and creating XXXX, Despite national we and demand in uptake market resources. campaign way XX% solutions. a in units marketing of we during the quarter line margin. by in the spend, prior reduced a year of the media but during members not growth between Due roughly raised the cash XX, our invest period of enough preserve so in we capital-intensive. same awareness awareness high record to continue we
and quarter. our an this impact guidance, previous reduced had investment marketing in with expected line As in revenues on the level of
an in or without the safety as Plenity's management that's Plenity the the two treatments weight rating personal We is FDA members, by patients FDA-regulated right confidence us empowering people's and proven prescription. for I'm control affordable available for with will obesity. extremely from we changing online. individuals Plenity An our has would active over of is wellness. take oral star available place weight Plenity lives Plenity to for scientifically pursue mission health as many in the to others greater time And to part the We and to that an pursuing to for to us pathway best-in-class of is to the become easily over accessible. that this is OTC be of XXX,XXX trusted available for continues And widely it are overweight application of Trustpilot Plenity in over-the-counter, communities need feedback classification with a and that make are our would getting important it demonstrated we product which one game-changer effective, change moved best managing OTC. X be an X proven gives obesity. out important an and patients, to and excited be OTC and for product. FDA. its Plenity some directly data, only of management itself announce believe available the reason, Making with excited their and private the struggling are overweight
OTC on reach to thereby simplify buying new for significantly profitability. consumer process, acquiring to the the lowering markets could reduces Importantly, vastly cost capital our change our of This members. Gelesis, reliance
strong example, interest portion already believe seeking are us the out much We significant already these simplifying will visit. larger but there drop-offs Plenity a For prescription, the during customers. give see people that buying online we physician of from process interested
we shift In be our distribution addition, to we product. people of consider are alternatives or to clearance simply possible more enables who to new who and work potential addressable earlier the could a in up the and aren't become prescription at middle of FDA become channels with market. prescription for open our now receive build were many to could the grow weight loss hesitant us by of channels potentially next partners part quarter to journey will part therapy the year the towards year. and the that sales This efficiently foundational sales management. to the long-term first application believe intend more also submit a target able for market We next We weight as of Plenity of
demonstrated study hydrogel, evaluated Additionally, study of the met asset, population typically profile primary LIGHT-UP pipeline prediabetes in properties that meetings of endpoints The LIGHT-UP even a lose effect safety several or an and new quarter a Plenity. type our harder shown scientific have similar our GSXXX, has people efficacy safety and greater we during that has has its the very diabetes. X to weight. which oral the presented time impressive in efficacy and in this study Paradoxically,
evaluating the GSXXX. are strategy now commercial We and best regulatory for
bring Plenity our value before of consequences, Gelesis and people with the obesity than deliver shareholders. of the important this for stronger many long-term treatment struggling potential we hard obesity obesity or to As advanced of to market millions downstream the to ever. beginning solution And shifts stages working preliminary is and of are
would I CFO, our financial walk the to turn to like to Now discussion. Maltz, Elliot through over our call
